Mutations in the p53 gene occur in almost all human tumors; however, they are not common in estrogen-responsive tumors (applies to only 20% of breast cancers, 18% of endometrial cancers, and 1.5% of cervical cancers) [121]. Here, TP53 is linked to endometrial cancer.